UpdatesPlus-IBD - Jan 2014
The January issue of UpdatesPlus-IBD is now available. This month we feature:
- Janssen's investigational biomarker approach to guide the selection of biologics
- New Humira data
- AdCom recommendation of vedolizumab and what this may mean to clinical practice
- Novel biologic approaches including engineered bacteria and colostrum antibodies for local delivery
- Two first in class pipeline entries
- Tyrosine kinase inhibition as a novel approach to IBD
0 Comments:
Post a Comment
<< Home